In what feels like the biggest health craze in years, weight loss jabs like semaglutide (Ozempic and Wegovy) or tirzepatide ...

An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...

Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...

Receiving a generic version of Ozempic or Wegovy from a compounding pharmacy is normally both easier to access and cheaper.

In a recent conversation with Managed Healthcare Executive, Geoffrey Rutledge, M.D., of HealthTap, warned that the narrative around GLP-1 drugs is often oversimplified—and potentially harmful.

Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!

A recent medical trial could help deliver the first daily weight loss pill capable of cutting down obesity as effectively as ...

Discover Mounjaro Tirzepatide's impact on obesity in India post its March launch. Get insights on effectiveness against ...

Fact checked by Nick Blackmer Hospital trips tied to semaglutide—the active ingredient in Ozempic and Wegovy—are rare, but ...

Tirzepatide (Mounjaro) launched in India in March 2025, promising new hope for diabetes and obesity treatment. An expert ...

Kapil Sharma's recent weight loss sparks speculation. Some fans wonder about his health. The article explores healthy weight loss. It emphasizes sustainable changes over quick fixes. Experts ...

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...